SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004131
Filing Date
2021-11-10
Accepted
2021-11-10 16:38:29
Documents
81
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eras-20210930.htm   iXBRL 10-Q 2945230
2 EX-31.1 eras-ex31_1.htm EX-31.1 16412
3 EX-31.2 eras-ex31_2.htm EX-31.2 16408
4 EX-32.1 eras-ex32_1.htm EX-32.1 8916
5 EX-32.2 eras-ex32_2.htm EX-32.2 9205
6 GRAPHIC img196845841_0.jpg GRAPHIC 87329
  Complete submission text file 0000950170-21-004131.txt   11594977

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eras-20210930_def.xml EX-101.DEF 290248
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eras-20210930_cal.xml EX-101.CAL 44346
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eras-20210930_lab.xml EX-101.LAB 557644
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eras-20210930.xsd EX-101.SCH 65727
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eras-20210930_pre.xml EX-101.PRE 432251
12 EXTRACTED XBRL INSTANCE DOCUMENT eras-20210930_htm.xml XML 2345473
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

IRS No.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40602 | Film No.: 211397317
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences